News Formal

Merck beats earnings expectations, raises outlook on strong Keytruda and vaccine sales

  • 📰 NBCLA
  • ⏱ Reading Time:
  • 38 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 19%
  • Publisher: 59%

Brasil Notícia Notícia

Brasil Últimas Notícias,Brasil Manchetes

The first-quarter results come as Merck shows substantial progress in preparing for Keytruda’s patent expiration in 2028.

Merck reported first-quarter revenue and adjusted earnings that topped expectations as it posted strong sales of its blockbuster cancer drug Keytruda and vaccine products.

The company expects full-year adjusted earnings of $8.53 to $8.65 per share, up from its prior forecast of $8.44 to $8.59 per share.of Harpoon Therapeutics in January. The company develops immune-based cancer drugs. The guidance also includes a negative impact of 30 cents per share from foreign exchange changes.

Excluding acquisition and restructuring costs, Merck earned $2.07 per share for the first quarter. Both adjusted and non-adjusted profit for the period include the charge related to the Harpoon deal.patent expiration Merck is also cutting costs under a new restructuring program it announced in February. Those efforts aim to improve the manufacturing network of both its pharmaceutical division and animal health business.

 

Obrigado pelo seu comentário. Seu comentário será publicado após ser revisado.
Resumimos esta notícia para que você possa lê-la rapidamente. Se você se interessou pela notícia, pode ler o texto completo aqui. Consulte Mais informação:

 /  🏆 319. in BR

Brasil Últimas Notícias, Brasil Manchetes

Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.

Stocks making the biggest moves premarket: Robinhood, GameStop, Merck and moreThese are the stocks posting the largest moves in premarket trading.
Fonte: CNBC - 🏆 12. / 72 Consulte Mais informação »

Stocks making the biggest moves midday: GameStop, Merck, Carnival, Cintas and moreThese are the stocks posting the largest moves in midday trading.
Fonte: CNBC - 🏆 12. / 72 Consulte Mais informação »

Cramer's week ahead: Earnings from Tesla, Merck and Big TechCNBC’s Jim Cramer said next week’s PCE index report will be the real gauge of inflation.
Fonte: NBCLA - 🏆 319. / 59 Consulte Mais informação »

Cramer’s week ahead: Earnings from Tesla, Merck and Big TechCNBC's Jim Cramer said next week's PCE index report will be the real gauge of inflation.
Fonte: CNBC - 🏆 12. / 72 Consulte Mais informação »